-
Product Insights
Kizomba C Field, Angola
Kizomba C upstream field is located in South Atlantic Ocean, Angola. The upstream field is owned by Azule Energy (42%); Equinor Energy AS (12%); Esso Exploration Angola (Block 15) Ltd (36%); Sonangol EP (10%). It is operated by Esso Exploration Angola (Block 15) Ltd. The project started its operations in 2008. Kizomba C Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well...
-
Product Insights
Copa C Field, Colombia
Copa C upstream field is located in Casanare, Colombia. The upstream field is owned by Frontera Energy Colombia Corp. It is operated by Frontera Energy Colombia Corp. The project started its operations in 2013. Copa C Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating costs. We...
-
Product Insights
Corcel C Field, Colombia
Corcel C upstream field is located in Meta, Colombia. The upstream field is owned by Frontera Energy Colombia Corp. It is operated by Frontera Energy Colombia Corp. The project started its operations in 2011. Corcel C Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating costs. We...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orbcel-C in Primary Sclerosing Cholangitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Orbcel-C in Primary Sclerosing CholangitisDrug Details:Stem cell therapy is under development for the treatment of primary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – C-106 in Idiopathic Pulmonary Fibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.C-106 in Idiopathic Pulmonary Fibrosis Drug Details:C-106 is under development for the treatment of idiopathic pulmonary...
-
Product Insights
Sirri C and D Field, Iran
Sirri C and D upstream field is located in Persian Gulf, Iran. The upstream field is owned by Iranian Offshore Oil Co. It is operated by Iranian Offshore Oil Co. The project started its operations in 2001. Sirri C and D Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and...
-
Product Insights
A. C. Amirov Project Field, Azerbaijan
A. C. Amirov Project upstream field is located in Absheron Region, Azerbaijan. The upstream field is owned by Azneft Production Association. It is operated by Azneft Production Association. The project started its operations in 2009. A. C. Amirov Project Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and...
-
Product Insights
K05-C Unit Field, Netherlands
K05-C Unit upstream field is located in North Sea, Netherlands. The upstream field is owned by EBN BV (50%); RockRose CS1 NL BV (11.66%); Total E&P Netherlands BV (36.31%); Vermilion Energy Netherlands BV (2.03%). It is operated by Total E&P Netherlands BV. The project started its operations in 1998. K05-C Unit Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key...
-
Product Insights
J03-C Unit Field, Netherlands
J03-C Unit upstream field is located in North Sea, Netherlands. The upstream field is owned by EBN BV (50%); RockRose CS1 NL BV (4.40%); Spirit Energy Nederland BV (20.60%); Total E&P Netherlands BV (25%). It is operated by Total E&P Netherlands BV. The project started its operations in 1996. J03-C Unit Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key...
-
Product Insights
Brigantine C Field, United Kingdom
Brigantine C upstream field is located in North Sea, United Kingdom. The upstream field is owned by Esso Exploration and Production UK Ltd (50%); Shell U.K. Ltd (50%). It is operated by Shell U.K. Ltd. The project started its operations in 2002. Brigantine C Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end...
-
Product Insights
K05-C North Field, Netherlands
K05-C North upstream field is located in North Sea, Netherlands. The upstream field is owned by EBN BV (50%); Total E&P Netherlands BV (50%). It is operated by Total E&P Netherlands BV. The project started its operations in 2011. K05-C North Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ropeginterferon Alfa-2B La in Hepatitis C
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ropeginterferon Alfa-2B La in Hepatitis CDrug Details: Ropeginterferon alpha-2b (Besremi) is a long acting interferon. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orbcel-C in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Orbcel-C in Crohn's Disease (Regional Enteritis) Drug Details:Stem cell therapy is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BVAC-C in Human Papillomavirus (HPV) Associated Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BVAC-C in Human Papillomavirus (HPV) Associated Cancer Drug Details:BVAC-C is under development for the treatment of...
-
Product Insights
Caracara Sur B Y C Field, Colombia
Caracara Sur B Y C upstream field is located in Meta, Colombia. The upstream field is owned by Cepsa Colombia SA (70%); Ecopetrol SA (30%). It is operated by Cepsa Colombia SA. The project started its operations in 2006. Caracara Sur B Y C Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end...